De Filippo Ovidio, Kang Jeehoon, Bruno Francesco, Song Young Bin, Campagnuolo Salvatore, Choi Ki Hong, Pinxterhuis Tineke H, Kim Hyun Kuk, Mattesini Alessio, Cho Yun-Kyeong, Piccolo Raffaele, Lee Hyun-Jong, Wańha Wojciech, Cortese Bernardo, Han Seung Hwan, Perl Leor, Hur Seung-Ho, Tuttolomondo Domenico, Iannaccone Mario, Chun Woo Jung, Greco Antonio, Leone Attilio, Giachet Alessandra Truffa, Gwon Hyeon-Cheol, Stefanini Giulio, Kim Hyo-Soo, Escaned Javier, Carmeci Antonino, Campo Gianluca, Patti Giuseppe, Capodanno Davide, von Birgelen Clemens, Koo Bon-Kwon, de Ferrari Gaetano Maria, Nam Chang-Wook, D'Ascenzo Fabrizio
Division of Cardiology, Cardiovascular and Thoracic Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
EuroIntervention. 2025 Mar 17;21(6):e318-e328. doi: 10.4244/EIJ-D-24-00471.
The impact of final kissing balloon inflation (FKB) in patients treated with an upfront provisional strategy for coronary bifurcation lesions is controversial.
We aimed to assess the impact of FKB on patient- and lesion-oriented outcomes in a large real-world cohort.
The ULTRA-BIFURCAT registry was obtained by patient-level merging the BIFURCAT and ULTRA registries. Pairs of patients were generated with propensity score matching (PSM). The primary outcome of interest was major adverse cardiac events (MACE) - a composite of all-cause death, myocardial infarction (MI), target lesion revascularisation (TLR) or stent thrombosis. A lesion-oriented composite outcome (LOCO) - a composite of target vessel MI (TVMI) or TLR - along with each single component of MACE represented the secondary outcomes. Subgroup analyses included the site of bifurcation (unprotected left main [ULM] vs non-ULM), side branch involvement (true bifurcation vs non-true bifurcation), side branch diameter and lesion length. Follow-up was censored at 800 days.
A total of 5,607 patients undergoing a provisional stenting technique were selected for the present analysis. PSM generated 1,784 pairs. Between the matched patients with FKB versus no FKB, no significant difference in MACE was observed (9.0% vs 8.6%; p=0.68). FKB was associated with a lower rate of the LOCO (1.9% vs 2.9%; p=0.04) compared to the no FKB group, driven by lower rates of TVMI (0.2% vs 0.5%; p=0.03) and TLR (1.8% vs 2.6%; p=0.14). These results were confirmed in the subgroups of patients treated for bifurcations with side branches with a diameter >2.5 mm and for true coronary bifurcation lesions.
Among patients treated for coronary bifurcation lesions with provisional stenting, FKB had no significant impact on MACE but was associated with a mild reduction in the incidence of the LOCO.
对于采用冠状动脉分叉病变初始临时策略治疗的患者,最终亲吻球囊扩张(FKB)的影响存在争议。
我们旨在评估FKB对一个大型真实世界队列中以患者和病变为导向的结局的影响。
通过患者层面合并BIFURCAT和ULTRA注册研究获得ULTRA - BIFURCAT注册研究。采用倾向评分匹配(PSM)生成成对患者。感兴趣的主要结局是主要不良心脏事件(MACE)——全因死亡、心肌梗死(MI)、靶病变血运重建(TLR)或支架血栓形成的复合事件。以病变为导向的复合结局(LOCO)——靶血管心肌梗死(TVMI)或TLR的复合事件——以及MACE的每个单一组成部分代表次要结局。亚组分析包括分叉部位(无保护左主干[ULM]与非ULM)、边支累及情况(真性分叉与非真性分叉)、边支直径和病变长度。随访在800天时进行截尾。
本分析共纳入5607例接受临时支架置入技术的患者。PSM生成1784对。在匹配的接受FKB与未接受FKB的患者之间,未观察到MACE有显著差异(9.0%对8.6%;p = 0.68)。与未接受FKB组相比,FKB与较低的LOCO发生率相关(1.9%对2.9%;p = 0.04),这是由较低的TVMI发生率(0.2%对0.5%;p = 0.03)和TLR发生率(1.8%对2.6%;p = 0.14)驱动的。这些结果在边支直径>2.5 mm的分叉病变治疗患者亚组和真性冠状动脉分叉病变患者亚组中得到证实。
在采用临时支架置入治疗冠状动脉分叉病变的患者中,FKB对MACE无显著影响,但与LOCO发生率的轻度降低相关。